Osteopontin Takes Center Stage in Chronic Liver Disease. Issue 4 (13th April 2021)

• Record Type: Journal Article
• Authors: Song, Zhuolun; Chen, Wei; Athavale, Dipti; Ge, Xiaodong; Desert, Romain; Das, Sukanta; Han, Hui; Nieto, Natalia
• Is Part Of: Hepatology. Volume 73:Issue 4(2021)
• Page Start: 1594
• Page End: 1608
• Publication Date: 2021-04-13
• Subjects: Heart -- Diseases -- Nursing -- Periodicals; Lungs -- Diseases -- Nursing -- Periodicals; Intensive care nursing -- Periodicals; Foie -- Maladies -- Périodiques; 616.362
• DOI: 10.1002/hep.31582
• Languages: English
• ISSNs: 0270-9139

Abstract

Abstract : Osteopontin (OPN) was first identified in 1986. The prefix osteo‐ means bone; however, OPN is expressed in other tissues, including liver. The suffix ‐pontin means bridge and denotes the role of OPN as a link protein within the extracellular matrix. While OPN has well‐established physiological roles, multiple "omics" analyses suggest that it is also involved in chronic liver disease. In this review, we provide a summary of the OPN gene and protein structure and regulation. We outline the current knowledge on how OPN is involved in hepatic steatosis in the context of alcoholic liver disease and non‐alcoholic fatty liver disease. We describe the mechanisms whereby OPN participates in inflammation and liver fibrosis and discuss current research on its role in hepatocellular carcinoma and cholangiopathies. To conclude, we highlight important points to consider when doing research on OPN and provide direction for making progress on how OPN contributes to chronic liver disease.